Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers

OBJECTIVES: The aim of this study was to assess the effects of concomitant administration of erenumab and sumatriptan on resting blood pressure, pharmacokinetics, safety, and tolerability in healthy subjects. METHODS: In this phase 1, parallel-group, one-way crossover, double-blind, placebo-controll...

Descripción completa

Detalles Bibliográficos
Autores principales: de Hoon, Jan, Van Hecken, Anne, Vandermeulen, Corinne, Herbots, Marissa, Kubo, Yumi, Lee, Ed, Eisele, Osa, Vargas, Gabriel, Gabriel, Kristin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348461/
https://www.ncbi.nlm.nih.gov/pubmed/29783863
http://dx.doi.org/10.1177/0333102418776017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348461/
https://www.ncbi.nlm.nih.gov/pubmed/29783863
http://dx.doi.org/10.1177/0333102418776017

Ejemplares similares